Latest Form 4 insider transactions

Todd B. Urness, a Director of Bridgewater Bancshares Inc, received 969 shares of common stock on September 30, 2026.

Thomas P. Trutna, a Director of Bridgewater Bancshares Inc, received 484 shares of common stock on September 30, 2026.

Joshua Horowitz, a Director of Kingsway Financial Services Inc, purchased 3,575 shares of common stock on September 28, 2026.

Gregory David Hoffmann, a Director of LEE ENTERPRISES, Inc, received 3,928 shares of common stock on September 28, 2026.

David B. Juran, a Director of Bridgewater Bancshares Inc, received 969 shares of common stock on September 30, 2026.

Lloyd Hoffman, CEO AND PRESIDENT and a Director of Alpha Pro Tech Ltd, reported multiple transactions in common stock on September 28, 2026.

Greg H Kubicek, a Director of Redwood Trust Inc, received 28,952 shares of common stock on September 30, 2026.

Standard BioTools has terminated a prior agreement and entered into a new definitive agreement to sell its mass cytometry business to Element Biosystems, LLC for $5.5 million in cash.

Brett Douglas Beldner, CFO of Hyperliquid Strategies Inc, received 82,781 shares of common stock on September 28, 2026.

David Ira Schamis, CEO and a Director of Hyperliquid Strategies Inc, received 248,344 shares of common stock on September 28, 2026.

Jeroen Nieuwkoop, Chief Operating Officer of Hyperliquid Strategies Inc, received 82,781 shares of common stock on September 28, 2026.

Artur Bergman, Chief Technology Officer and a Director of Fastly, Inc., sold 37,039 shares of common stock on September 28, 2026.

Laura Lee Stewart, Chief Executive Officer and a Director of Sound Financial Bancorp, Inc., sold 900 shares of common stock on September 30, 2026 for $45.99 per share.

Michael Hsing, CEO and a Director of Monolithic Power Systems Inc, sold 30,000 shares of common stock on September 28, 2026.

Mauro Stocchi, See Remarks of Stevanato Group S.p.A., sold 13,649 shares of common stock on September 28, 2026 for $21.50 per share.

Newbury Street II Acquisition Corp. announces engagement of Donerail Group for advisory services and confidential submission of a draft registration statement for its business combination with Fort Robotics.

BX Buzz ML-1 GP LLC and 9 others reported changes in beneficial ownership of Blackstone Inc. common stock on September 28, 2026.

BX Buzz ML-1 GP LLC and 9 others reported changes in beneficial ownership of Bumble Inc. common stock on September 28, 2026.

Robert E. Gagnon, a Director of Bone Biologics Corp, received 113,896 shares of common stock on September 28, 2026.

Donna Millar, a Director and 10% owner of Alpha Pro Tech Ltd, sold 6,971 shares of common stock on September 28, 2026 for $5.04 per share.

Horvath D Debora, a Director of Redwood Trust Inc, received 15,059 shares of common stock on September 30, 2026.

Kimberly S Lubel, a Director of Arcosa, Inc., reported a transaction in 2,398 shares of common stock on September 29, 2026.

Siddhesh Rajendra Angle, a Director of Bone Biologics Corp, received 113,896 shares of common stock on September 28, 2026.

Maurice S Smith, a Director of Halliburton Co, received 1,162 shares of common stock on September 30, 2026.

Xiaodong Wang, a Director of BeiGene, Ltd., sold 31,028 shares of common stock on September 28, 2026.

William P Scully, a 10% owner of Prothena Corp Public Ltd Co, purchased 162,000 shares of common stock on September 29, 2026 for $8.68 per share.

Phillip Terry Meikle Ii, a Director of Bone Biologics Corp, received 113,896 shares of common stock on September 28, 2026.

Blackstone Holdings III GP Management L.L.C. and 9 others reported changes in beneficial ownership of Bumble Inc. common stock on September 28, 2026.

Na Li, CFO and Director and a Director of Linkhome Holdings Inc., sold 30,000 shares of common stock on April 28, 2026 for $1.50 per share.

Bruce Stroever, a Director of Bone Biologics Corp, received 113,896 shares of common stock on September 28, 2026.